共 148 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2013)Gonadotrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial Obstet Gynecol 121 78-86
[3]
Soerjomataram I(2014)Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents Hum Reprod Update 20 759-774
[4]
Siegel RL(2014)Fertility after breast cancer treatment Eur J Obstet Gynecol Reprod Biol 173 13-18
[5]
Torre LA(2017)Fertility, ovarian reserve and cancer Maturitas 105 64-68
[6]
Jemal A(2011)Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial J Clin Oncol 29 1110-1116
[7]
Elgindy EA(2019)Ovarian effects of radiation and cytotoxic chemotherapy damage Best Pract Res Clin Obstet Gynaecol 55 37-48
[8]
El-Haieg DO(2012)Methotrexate: a detailed review on drug delivery and clinical aspects Expert Opin Drug Deliv 9 151-169
[9]
Khorshid OM(2015)Anti-Müllerian hormone and assessment of ovarian toxic treatment: a systematic narrative review Reprod Sci 22 519-526
[10]
El I(2016)Propranolol and oxytocin versus oxytocin alone for induction and augmentation of labor: a meta-analysis of randomized trials Arch Gynecol Obstet 293 721-729